India Boasts Profitable Adult Stem Cell Market
While other countries are still trying to figure out what their federal regulatory laws should be, India is providing a fertile, friendly, and profitable market for new adult stem cell companies.
While other countries are still trying to figure out what their federal regulatory laws should be, India is providing a fertile, friendly, and profitable market for new adult stem cell companies.
The University of California at Davis has been awarded two separate multi-million-dollar grants for the study of adult stem cells in the treatment of various neurodegenerative and blood diseases.
The adult stem cell company Stemedica has requested a meeting with the FDA as the first step in the clinical evaluation of its proprietary adult stem cell product for the treatment of ischemic stroke.
In an innovative application of laboratory technology, scientists observe a "movie" of adult stem cells in the process of repairing the brain.
Doctors in India are using autologous adult stem cells to treat Parkinson’s disease in a 55-year-old patient.
A group describing themselves as "pro-embryo" has filed a lawsuit against NIH, claiming that the new stem cell policy of the Obama administration violates federal law.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2024, Stem Cell Insitute Panama. All rights reserved.